Chemoinformaics analysis of Furazane-3-carbohydrazide, 4-amino-N2-(2-chlorobenzylideno)-
Molecular Weight | 265.66 | nRot | 3 |
Heavy Atom Molecular Weight | 257.596 | nRig | 14 |
Exact Molecular Weight | 265.037 | nRing | 2 |
Solubility: LogS | -3.68 | nHRing | 1 |
Solubility: LogP | 2.802 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 1 |
nHetero | 8 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 5 | No. of Arom Atom | 11 |
No. of Oxygen atom | 2 | No. of Arom Bond | 11 |
nHA | 6 | APOL | 31.3183 |
nHD | 2 | BPOL | 11.1397 |
QED | 0.567 |
Synth | 3.06 |
Natural Product Likeliness | -1.823 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.089 |
HIA | 0.007 |
CACO-2 | -5.334 |
MDCK | 0.0000187 |
BBB | 0.949 |
PPB | 0.963344 |
VDSS | 0.725 |
FU | 0.037218 |
CYP1A2-inh | 0.915 |
CYP1A2-sub | 0.601 |
CYP2c19-inh | 0.665 |
CYP2c19-sub | 0.083 |
CYP2c9-inh | 0.163 |
CYP2c9-sub | 0.47 |
CYP2d6-inh | 0.76 |
CYP2d6-sub | 0.362 |
CYP3a4-inh | 0.229 |
CYP3a4-sub | 0.182 |
CL | 2.031 |
T12 | 0.752 |
hERG | 0.008 |
Ames | 0.198 |
ROA | 0.069 |
SkinSen | 0.666 |
Carcinogencity | 0.943 |
EI | 0.721 |
Respiratory | 0.983 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.631358 |